Los agonistas del receptor del GLP-1: un abordaje terapéutico eficaz de amplio espectro en el tratamiento de la diabetes mellitus tipo 2

Med Clin (Barc). 2014:143 Suppl 2:1. doi: 10.1016/S0025-7753(14)70100-9.
[Article in Spanish]
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Delayed-Action Preparations
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Exenatide
  • Glucagon-Like Peptide-1 Receptor / agonists*
  • Humans
  • Hypoglycemic Agents / pharmacokinetics
  • Hypoglycemic Agents / therapeutic use*
  • Peptides / pharmacokinetics
  • Peptides / therapeutic use*
  • Treatment Outcome
  • Venoms / pharmacokinetics
  • Venoms / therapeutic use*

Substances

  • Delayed-Action Preparations
  • Glucagon-Like Peptide-1 Receptor
  • Hypoglycemic Agents
  • Peptides
  • Venoms
  • Exenatide